Oxidative and Non-Oxidative Metabolomics of Ethanol.

Abstract:

BACKGROUND:It is well known that ethanol can cause significant morbidity and mortality, and much of the related toxic effects can be explained by its metabolic profile. OBJECTIVE:This work performs a complete review of the metabolism of ethanol focusing on both major and minor metabolites. METHOD:An exhaustive literature search was carried out using textual and structural queries for ethanol and related known metabolizing enzymes and metabolites. RESULTS:The main pathway of metabolism is catalyzed by cytosolic alcohol dehydrogenase, which exhibits multiple isoenzymes and genetic polymorphisms with clinical and forensic implications. Another two oxidative routes, the highly inducible CYP2E1 system and peroxisomal catalase may acquire relevance under specific circumstances. In addition to oxidative metabolism, ethanol also originates minor metabolites such as ethyl glucuronide, ethyl sulfate, ethyl phosphate, ethyl nitrite, phosphatidylethanol and fatty acid ethyl esters. These metabolites represent alternative biomarkers since they can be detected several hours or days after ethanol exposure. CONCLUSION:It is expected that knowing the metabolomics of ethanol may provide additional insights to better understand the toxicological effects and the variability of dose response.

journal_name

Curr Drug Metab

journal_title

Current drug metabolism

authors

Dinis-Oliveira RJ

doi

10.2174/1389200217666160125113806

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

327-35

issue

4

eissn

1389-2002

issn

1875-5453

pii

CDM-EPUB-73206

journal_volume

17

pub_type

杂志文章,评审
  • Functional expression of human cytochrome P450 enzymes in Escherichia coli.

    abstract::Knowledge regarding cytochrome P450 (P450) is crucial to the fields of drug therapy and drug development, as well as in our understanding of the mechanisms underlying the metabolic activation of potentially toxic and carcinogenic compounds. Escherichia coli is the most extensively utilized host in the production of re...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920006776873472

    authors: Yun CH,Yim SK,Kim DH,Ahn T

    更新日期:2006-05-01 00:00:00

  • New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II.

    abstract::Part I of this article published in the previous issue of Current Drug Metabolism discussed the substrate specificity, inhibitor selectivity and structure-activity relationship (SAR) of human CYP2C9. The features of CYP2C9 pharmacophore and SAR models have been elaborated. Part II of this article will address the homo...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920009790820101

    authors: Mo SL,Zhou ZW,Yang LP,Wei MQ,Zhou SF

    更新日期:2009-12-01 00:00:00

  • Tubular and Glomerular Biomarkers of Acute Kidney Injury in Newborns.

    abstract:BACKGROUND:Acute Kidney Injury (AKI) is a sudden decrease in kidney function. In the early period, the highest percentage of AKI occurs among newborns hospitalized in the neonatal intensive care units, especially premature neonates. The prognosis of AKI depends on the type and severity of the cause of an injury, the ac...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200220666190321142417

    authors: Kamianowska M,Szczepański M,Wasilewska A

    更新日期:2019-01-01 00:00:00

  • Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer's Disease.

    abstract::A amyloid-β (Aβ) plaque formation in the brain is known to be the root cause of Alzheimer's disease (AD), which affects the behavior, memory, and cognitive ability in humans. The brain starts undergoing changes several years before the actual appearance of the symptoms. Nanotechnology could prove to be an alternative ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666201124140518

    authors: Chauhan PS,Yadav D,Koul B,Mohanta YK,Jin JO

    更新日期:2020-01-01 00:00:00

  • Nanotechnologies: a strategy to overcome blood-brain barrier.

    abstract::The possibility to treat central nervous system (CNS) disorders is strongly limited by the poor access of many therapeutic agent to the target tissues. This is mainly due to the presence of the blood-brain barrier (BBB), formed by a complex interplay of endothelial cells, astrocyte and pericytes, through which only se...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920012798356943

    authors: De Rosa G,Salzano G,Caraglia M,Abbruzzese A

    更新日期:2012-01-01 00:00:00

  • Impact of various factors on pharmacokinetics of bioactive polyphenols: an overview.

    abstract::Several epidemiological studies throughout the years have suggested that polyphenols from fruits and vegetables promote health and reduce the risk of certain chronic and neurodegenerative diseases. Yet, it has been proved to be extremely difficult to quantitatively establish the benefit afforded by polyphenols, princi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200214666131210144115

    authors: Rubió L,Macià A,Motilva MJ

    更新日期:2014-01-01 00:00:00

  • Reaction phenotyping in drug discovery: moving forward with confidence?

    abstract::For the pharmaceutical industry, one of the challenges in evaluating the risk of future compound attrition at the discovery stage is the successful prediction of the major routes of clearance in humans. For compounds cleared by metabolism, such information will help to avoid the development of compounds that will exhi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200033489235

    authors: Williams JA,Hurst SI,Bauman J,Jones BC,Hyland R,Gibbs JP,Obach RS,Ball SE

    更新日期:2003-12-01 00:00:00

  • Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity.

    abstract:BACKGROUND:Kidney dysfunction resulting from various drugs is an important issue during the drug development process. Traditional in vivo animal experiments are limited with respect to evaluating drug efficacy and nephrotoxicity due to discrepancies in drug pharmacokinetics and pharmacodynamics between humans and anima...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180309101844

    authors: Lee J,Kim S

    更新日期:2018-01-01 00:00:00

  • Xenobiotic-CoA ligases: kinetic and molecular characterization.

    abstract::This review focuses primarily on the mammalian medium and long-chain fatty acid coenzyme A ligases that have been implicated in the metabolism of xenobiotic carboxylic acids such as pesticides, arylpropionate non steroidal anti-inflammatory drugs and the hypolipidaemic clofibrate and its congeners. Evidence of multipl...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200003339261

    authors: Knights KM,Drogemuller CJ

    更新日期:2000-07-01 00:00:00

  • Toxicogenomics.

    abstract::Toxicogenomics is defined as an integration of genomics (transcriptomics, proteomics and metabolomics) and toxicology. It is a scientific field that studies how the genome is involved in responses to environmental stressors and toxicants. It combines studies of mRNA expression, cell and tissue-wide protein expression ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008783884696

    authors: Gomase VS,Tagore S

    更新日期:2008-03-01 00:00:00

  • Polymer-based cancer nanotheranostics: retrospectives of multi-functionalities and pharmacokinetics.

    abstract::The pressing need for targeting, detecting, monitoring, and treating diseased cells concomitantly gives rise to multi-functional nanomedicines, especially those that can combine diagnostic and therapeutic abilities, which are referred to as nanotheranostics. Recently, nanotheranostics are of significant clinical inter...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200211314060003

    authors: Han N,Yang YY,Wang S,Zheng S,Fan W

    更新日期:2013-07-01 00:00:00

  • The role of mass spectrometry in biomarker discovery and measurement.

    abstract::Recent advances in the biological and analytical sciences have led to unprecedented interest in the discovery and quantitation of endogenous molecules that serve as indicators of drug safety, mechanism of action, efficacy, and disease state progression. By allowing for improved decision-making, these indicators, refer...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920006777697918

    authors: Ackermann BL,Hale JE,Duffin KL

    更新日期:2006-06-01 00:00:00

  • Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System.

    abstract::To understand the sophisticated dynamic behaviors of drug elution and permeation in the gastrointestinal tract (GIT), researchers have tried to reemerge it by employing various in vitro experimental models. However, official in vitro apparatuses routinely used for quality control purposes, employ simple, non-physiolog...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200216666150812123836

    authors: Li Z,He X

    更新日期:2015-01-01 00:00:00

  • Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs.

    abstract::Ophthalmic drugs are delivered to ocular tissues predominantly via relatively simple formulations, such as topically dosed water-soluble drug solutions and water-insoluble drug suspensions in ointments. An ideal topical drug delivery system should possess certain desirable properties, such as good corneal and conjunct...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920007779815977

    authors: Bu HZ,Gukasyan HJ,Goulet L,Lou XJ,Xiang C,Koudriakova T

    更新日期:2007-02-01 00:00:00

  • Liver-based in vitro technologies for drug biotransformation studies - a review.

    abstract::Early understanding of the metabolic pathway and potential interaction of new drug candidates with other drugs is one of the goals of preclinical studies in the drug discovery process. Although other body organs are involved in drug biotransformation, the liver is the predominant organ of metabolism for a wide range o...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920012798918426

    authors: Fasinu P,Bouic PJ,Rosenkranz B

    更新日期:2012-02-01 00:00:00

  • Drug metabolism in chronic renal failure.

    abstract::Pharmacokinetic studies conducted in patients with CRF demonstrate that the nonrenal clearance of multiple drugs is reduced. Although the mechanism by which this occurs is unclear, several studies have shown that CRF affects the metabolism of drugs by inhibiting key enzymatic systems in the liver, intestine and kidney...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200033489532

    authors: Pichette V,Leblond FA

    更新日期:2003-04-01 00:00:00

  • The recent development of nanoparticles for brain tumor targeting delivery.

    abstract::Superparamagnetic iron oxide nanoparticles (SPIONs) have attracted a lot of interest due to their widespread diagnostic and therapeutic applications in neuro-oncology. Functinalization of the particles surface with targeting molecules that recognize tumor receptors might be exploited for the specific brain tumor targe...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:

    authors: Shevtsov MA

    更新日期:2016-06-15 00:00:00

  • Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy.

    abstract:OBJECTIVE:Tyrosine kinase inhibitors (TKIs) are widely used drugs which have high availability in reducing the activity of BCR-ABL1 tyrosine kinase, therefore they play an indispensable role in the treatment of Chronic myeloid leukemia (CML). Imatinib, dasatinib and nilotinib have been proved to have absolute bioavaila...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200218666170116113705

    authors: Wang R,Zhong C,Zhang C,Hua M,Ma D

    更新日期:2017-01-01 00:00:00

  • Physiologically-Based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-Drug Interactions.

    abstract::Membrane transporters play an important role in intestinal absorption, distribution and clearance of drugs. Additionally transporters along with enzymes regulate tissue exposures (e.g. liver, kidney and brain), which are important for safety and efficacy considerations. Early identification of transporters involved gu...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221999210101233340

    authors: Taskar KS,Harada I,Alluri RV

    更新日期:2021-01-01 00:00:00

  • Herb-Drug Interactions and Hepatotoxicity.

    abstract:BACKGROUND:In recent times, herbals or phytomedicines have become very popular due to their global acceptance as a complementary and alternative remedy. While modern drugs are commercially available only after laboratory validations, clinical trials, as well as approval from drug regulatory authorities, majority of the...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200220666190325141422

    authors: Parvez MK,Rishi V

    更新日期:2019-01-01 00:00:00

  • Interactions of liposomes with cells in vitro and in vivo: opsonins and receptors.

    abstract::A number of studies have appeared recently on the underlying mechanisms of liposome-cell interactions under in vitro conditions, in which isolated cell populations or cell lines were used. However, our knowledge of how liposomes interact with cells and the parameters that influence this in vivo is limited. We will sum...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200013338306

    authors: Ishida T,Harashima H,Kiwada H

    更新日期:2001-12-01 00:00:00

  • Effect of environmental substances on the activity of arylamine N-acetyltransferases.

    abstract::Arylamine N-acetyltransferases (NAT) are xenobiotic-metabolizing enzymes responsible for the acetylation of many aromatic arylamine and heterocyclic amines, thereby playing an important role in both detoxification and activation of numerous drugs and carcinogens. Two closely related isoforms (NAT1 and NAT2) have been ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008784892092

    authors: Rodrigues-Lima F,Dairou J,Dupret JM

    更新日期:2008-07-01 00:00:00

  • On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance.

    abstract::Thiopurines such as azathioprine, 6-mercaptopurine and 6-thioguanine are antimetabolites that have been used for several decades in the treatment of several diseases including inflammatory bowel diseases. Additional anti-inflammatory properties of these thiopurines have been discovered in recent years. Thiopurine meta...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920009790711887

    authors: Van Asseldonk DP,de Boer NK,Peters GJ,Veldkamp AI,Mulder CJ,Van Bodegraven AA

    更新日期:2009-11-01 00:00:00

  • Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice.

    abstract::Human genome sequencing highlights the involvement of genetic variation towards differential risk of human diseases, presence of different phenotypes, and response to pharmacological elements. This brings the field of personalized medicine to forefront in the era of modern health care. Numerous recent approaches have ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200217666160804150959

    authors: Prakash S,Agrawal S

    更新日期:2016-01-01 00:00:00

  • Nanotechnology in Disease Diagnostic Techniques.

    abstract::Currently the major research highlights of bioengineering and medical technology are directed towards development of improved diagnostic techniques to screen complex diseases. Screening requirements are to identify the cause of illnesses, monitor improvement or progression of the state of diseases such as cancer, card...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Savaliya R,Shah D,Singh R,Kumar A,Shanker R,Dhawan A,Singh S

    更新日期:2015-01-01 00:00:00

  • Pharmacokinetic and metabolism determinants of fluoropyrimidines and oxaliplatin activity in treatment of colorectal patients.

    abstract::Fluoropyrimidines and oxaliplatin continued to be the mainstay of therapeutic regimens in the treatment of colorectal cancer (CRC). For this reason, pharmacokinetic and metabolism of these drugs were analyzed and the identification of accurate and validated predictive, prognostic and toxicity markers became necessary ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011798062300

    authors: Gnoni A,Russo A,Silvestris N,Maiello E,Vacca A,Marech I,Numico G,Paradiso A,Lorusso V,Azzariti A

    更新日期:2011-12-01 00:00:00

  • Safety and tolerability of agomelatine: focus on hepatotoxicity.

    abstract::Hepatotoxicity related to antidepressive pharmacotherapy is a major safety concern, particularly considering that severe forms of hepatic failure with fatal outcome have been reported. Severe hepatotoxic adverse drug reactions were also reported for agomelatine (AGM), an antidepressive agent, which was approved for th...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200215666140926155041

    authors: Gahr M,Kratzer W,Fuchs M,Connemann BJ

    更新日期:2014-01-01 00:00:00

  • Changes of Transporters and Drug-metabolizing Enzymes in Nephrotic Syndrome.

    abstract:BACKGROUND:Drug-metabolizing enzymes and transporters play key roles in drug disposition and drug interactions. The alterations of their expression will influence drug pharmacokinetics and pharmacodynamics. However, the changes in the expression of enzymes and transporters in the disease state are still unclear. OBJEC...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666200512113731

    authors: Dong Y,Gong L,Lu X,Ye M,Lin Y,Xie S,Zhang J,Zhou F,Tang L,Zou W,Liu M

    更新日期:2020-01-01 00:00:00

  • Research/review: Structure and linkage disequilibrium analysis of adamantane resistant mutations in influenza virus m2 proton channel.

    abstract::The M2 proton channel is translated by the M gene segment of influenza viruses, and has been adopted as an attractive target for influenza A viruses, on which a series of adamantane-based drugs act. However, recently epidemic influenza viruses have had strong resistant effects against the adamantane-based drugs. In th...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200215666140605130406

    authors: Yu Y,Li X,Hao P,Wang JF,Chou KC

    更新日期:2014-01-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials.

    abstract::There are several clinically useful endoperoxides, mainly artemisinin derivatives available in market for the treatment of malaria. These are highly potent drugs, with fastest parasite reduction ratio, broadest parasite stage specificity and effectiveness against all species of plasmodium in human. Endoperoxides are c...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920009787846323

    authors: Gautam A,Ahmed T,Batra V,Paliwal J

    更新日期:2009-03-01 00:00:00